Jerome Massardier
Overview
Explore the profile of Jerome Massardier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renoux C, Roland E, Ruet S, Zouaghi S, Michel M, Joly P, et al.
Int J Neonatal Screen
. 2024 Dec;
10(4).
PMID: 39728397
In France, sickle cell disease newborn screening (SCD NBS) has been targeted to at-risk regions since 1984, but generalization to the whole population will be implemented from November 2024. Although...
2.
Msika A, Mathias V, Boudigou M, Chambon M, Dubois V, Hajri T, et al.
Am J Obstet Gynecol
. 2024 Oct;
PMID: 39370035
Background: Low-risk gestational trophoblastic neoplasia are currently receiving monochemotherapy as first-line therapy. In the case of a resistance, a second-line monochemotherapy or polychemotherapy is proposed. As an alternative to these...
3.
Weber M, Monier I, Rahshenas M, Salomon L, Sananes N, Castaigne V, et al.
Prenat Diagn
. 2024 Aug;
44(12):1536-1547.
PMID: 39138024
Objective: To assess the frequency of fetal therapy for fetuses with congenital pulmonary malformations (CPMs) and to investigate their short-term outcomes. Method: The study population included 435 singleton fetuses diagnosed...
4.
Pannier E, Sekri A, Roux N, Vasiljevic A, El Khattabi L, Chatron N, et al.
Birth Defects Res
. 2024 Jul;
116(7):e2380.
PMID: 38980211
Background: Fontaine progeroid syndrome (FPS, OMIM 612289) is a recently identified genetic disorder stemming from pathogenic variants in the SLC25A24 gene, encoding a mitochondrial carrier protein. It encompasses Gorlin-Chaudry-Moss syndrome...
5.
Lepee A, Massardier J, Atallah A, Massoud M, Pettazzoni M, Huissoud C, et al.
Fetal Diagn Ther
. 2024 Jun;
51(5):486-492.
PMID: 38934150
Introduction: Congenital microgastria (CM) is a rare condition due to early interruption of stomach development between the 4th and 8th week of gestation, leading to a small midline tubular stomach....
6.
Dreux S, Rosenblatt J, Massardier J, Benachi A, Voirin-Mathieu E, Muller F
Prenat Diagn
. 2024 May;
44(8):959-964.
PMID: 38757850
Aim: This aim of this study was to detail maternal and fetal anomalies observed on a national scale in a large French cohort of patients presenting high hCG values (≥10...
7.
Lefevre C, Collardeau-Frachon S, Streichenberger N, Berenguer-Martin S, Clemenson A, Massardier J, et al.
J Inherit Metab Dis
. 2023 Nov;
47(2):255-269.
PMID: 38012812
Glycogen storage disease type IV (GSD IV), also called Andersen disease, or amylopectinosis, is a highly heterogeneous autosomal recessive disorder caused by a glycogen branching enzyme (GBE, 1,4-alpha-glucan branching enzyme)...
8.
Hajri T, Massoud M, Vergne M, Descargues P, Allias F, You B, et al.
Am J Obstet Gynecol
. 2023 Sep;
230(3):362.e1-362.e8.
PMID: 37722570
Background: Multiple pregnancy with a complete hydatidiform mole and a normal fetus is prone to severe obstetrical complications and malignant transformation after birth. Prognostic information is limited for this rare...
9.
Donzel M, Gaillot-Durand L, Joubert M, Aziza J, Beneteau C, Mauduit C, et al.
Virchows Arch
. 2023 Sep;
483(5):709-715.
PMID: 37695410
Hydatidiform moles (HMs) are divided into two types: partial hydatidiform mole (PHM) which is most often diandric monogynic triploid and complete hydatidiform mole (CHM) which is most often diploid androgenetic....
10.
Raffin D, Descargues P, Hajri T, Massardier J, You B, Lotz J, et al.
J Gynecol Obstet Hum Reprod
. 2023 Jul;
52(8):102636.
PMID: 37500013
Background: Liver metastases of gestational trophoblastic neoplasia (GTN) are rare, but associated with poor prognosis. The additional concomitant presence of brain or intra-abdominal metastases, with liver metastases has been described...